Exploring the cell death mechanisms of cytotoxic [1,2,3]triazolylcarborane lead compounds against U87 MG human glioblastoma cells
Chemical Biology & Drug Design · 2023-06 · 101 (6) · 1435-1445
DOI: 10.1111/cbdd.14208 ↗At a glance
Leserbrief in Chemical Biology & Drug Design, published online on 2023-02-15. Written by Catalina Alamón and 3 co-authors. Institution: Grupo de Química Orgánica Medicinal, Instituto de Química Biológica, Facultad de Ciencias, Universidad de la República, Montevideo, Uruguay. Major MEDLINE topics: Glioblastoma, Antineoplastic Agents. Cited 8 times so far (Crossref); 20 references. Funded by: Agencia Nacional de Investigación e Innovación.
Abstract (original language)
Moving towards high‐grade glioma drug discovery, this study aimed to detect the mechanism of cellular death (apoptosis, necrosis and/or autophagy) induced by three carboranyl‐based lead compounds. For that, we performed in U87 MG cells, flow cytometry experiments, as the gold standard technique, as well as confocal microscopy and 1 H‐NMR experiments as non‐invasive assays. We selected three hybrid leads ( 1–3 ) from the in‐house‐library and the corresponding parent compounds, and recognized tyrosine kinase inhibitors (lapatinib, sunitinib and erlotinib) to put to the test in these experiments. Flow cytometry with Annexin V‐FITC/DAPI staining showed that leads 1 and 3 and lapatinib mainly induced necrosis in U87 MG upon a 24 h treatment at IC 50 dose; meanwhile, hybrid 2 , sunitinib and erlotinib seem to induce apoptosis in such cells. In general, confocal microscopy studies were in agreement with flow cytometry observing loss of cell membrane integrity in necrotic cells and features of apoptosis, that is, chromatin condensation, in apoptotic cells. Finally, NMR results showed that glioblastoma cells treated with hybrid 1 , 3 or lapatinib displayed changes in CH 2 /CH 3 signal ratio and choline signals that could indicate necrotic cell death mechanism: meanwhile, 2 ‐, sunitinib‐ or erlotinib‐treated cells showed apoptotic characteristic behaviors. Additionally, carboranyl‐hybrid 2 also produced autophagy in U87 MG cells.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Grupo de Química Orgánica Medicinal, Instituto de Química Biológica, Facultad de Ciencias, Universidad de la República, Montevideo, Uruguay.
- Área de Radiofarmacia, Centro de Investigaciones Nucleares, Facultad de Ciencias, Universidad de la República, Montevideo, Uruguay.
Funding
- Agencia Nacional de Investigación e Innovación
Cite
APA
Alamón, C., Dávila, B., Cerecetto, H., & Couto, M. (2023). Exploring the cell death mechanisms of cytotoxic [1,2,3]triazolylcarborane lead compounds against U87 MG human glioblastoma cells. Chemical Biology & Drug Design, 101(6), 1435-1445. https://doi.org/10.1111/cbdd.14208
Vancouver
Alamón C, Dávila B, Cerecetto H, Couto M. Exploring the cell death mechanisms of cytotoxic [1,2,3]triazolylcarborane lead compounds against U87 MG human glioblastoma cells. Chemical Biology & Drug Design. 2023;101(6):1435-1445. doi:10.1111/cbdd.14208
BibTeX
@article{Alamn2023,
author = {Alamón, Catalina and Dávila, Belén and Cerecetto, Hugo and Couto, Marcos},
title = {Exploring the cell death mechanisms of cytotoxic [1,2,3]triazolylcarborane lead compounds against U87 MG human glioblastoma cells},
journal = {Chemical Biology & Drug Design},
year = {2023},
volume = {101},
number = {6},
pages = {1435--1445},
doi = {10.1111/cbdd.14208}
}
EUVIMED